Although still below target levels, current malaria interventions have substantially reduced malaria disease incidence across the continent. Increasing access to these interventions, and maintaining their effectiveness in the face of insecticide and drug resistance, should form a cornerstone of post-2015 control strategies.
Malaria, leishmaniasis, lymphatic filariasis, and dengue are prime candidates for combined vector control. All four of these diseases overlap considerably in their distributions and there is a growing body of evidence for the effectiveness of insecticide-treated nets, screens, and curtains for controlling all of their vectors. The real-world effectiveness of cross-disease vector control programmes can only be evaluated by large-scale trials, but there is clear evidence of the potential of such an approach to enable greater overall health benefit using the limited funds available.
This article, published in Nature found that Plasmodium falciparum infection prevalence in endemic Africa halved and the incidence of clinical disease fell by 40% between 2000 and 2015. Interventions have averted an estimated 663 (542–753 credible interval) million clinical cases since 2000. Insecticide-treated nets, the most widespread intervention, were by far the largest contributor (68% of cases averted).
Author: Battle KE, Bennett A, Bhatt S, Bisanzio D, Briet O, Cameron E, Cibulskis RE, Cohen JM, Dalrymple U, Eckhoff P, Eisele TP, Fergus CA, Gething PW, Griffin JT, Hay SI, Henry A, Lindgren F, Lynch M, Mappin B, Moyes CL, Murray CLJ, Penny MA, Smith DL, Smith TA, Weiss J, Wenger E, Yukich J
Publication date: September 2015
An analysis of malaria control funding from international donors, bilateral sources, and national governments using a review that was undertaken to reconstruct total funding by country for each year, 2006 to 2010.